← FDA DRUG APPROVALS

FDA NDA · NDA019401

PSEUDO-12

Sponsor: UCB INC

APPLICATION
NDA019401
TYPE
NDA
ORIGINAL APPROVAL
1987-06-19
LATEST ACTION
1987-06-19
ROUTE
ORAL
DOSAGE FORM
SUSPENSION, EXTENDED RELEASE
MARKETING STATUS
Discontinued

Products

PSEUDO-12Discontinued
PSEUDOEPHEDRINE POLISTIREX EQ 60MG HYDROCHLORIDE/5ML · SUSPENSION, EXTENDED RELEASE · ORAL

Approval history

1987-06-19Type 2 - New Active Ingredient and Type 3 - New Dosage Form · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →